Athyrium Capital Management as of March 31, 2023
Portfolio Holdings for Athyrium Capital Management
Athyrium Capital Management holds 8 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Amryt Pharma Sponsored ADS | 46.3 | $129M | 8.9M | 14.58 | |
Biora Note 7.250% 12/0 (Principal) | 20.8 | $58M | 104M | 0.56 | |
Omeros Corp Note 5.250% 2/1 (Principal) | 16.7 | $47M | 65M | 0.71 | |
Rvl Pharmaceuticals SHS (RVLPQ) | 6.0 | $17M | 15M | 1.14 | |
Omeros Corp Note 6.250%11/1 (Principal) | 4.0 | $11M | 11M | 1.01 | |
Paratek Pharmaceuticals Note 4.750% 5/0 (Principal) | 2.7 | $7.4M | 9.0M | 0.82 | |
Puma Biotechnology (PBYI) | 2.0 | $5.5M | 1.8M | 3.09 | |
Biora Therapeutics Ord (BIOR) | 1.7 | $4.7M | 1.7M | 2.77 |